©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4986-5003
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
| Severity | Criteria | Treatment | Comments |
| First episode | |||
| Stop all non-CDI related antibiotic therapy if possible | |||
| Mild to moderate disease | Diarrhea and symptoms not meeting criteria for severe disease | Metronidazole 500 mg by mouth 3 times per day for 10 d to 14 d | In hospitalized patients with UC and nonsevere CDI, treatment with a vancomycin-containing regimen vs metronidazole alone resulted in fewer readmissions and shorter LOS[70] |
| or | |||
| Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |||
| Severe disease | Serum albumin < 3 g/dL AND one of the following: | Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |
| WBC ≥ 15000 cells/mm3 | |||
| Abdominal tenderness | |||
| Creatinine ≥ 133 μmol/L | |||
| Severe, complicated disease | Admission to intensive care unit | Vancomycin 500 mg by mouth or nasogastric tube 4 times per day | Consider early surgical consultation |
| Hypotension ± vasopressor requirement | and | ||
| Fever ≥ 38.5 °C | Metronidazole 500 mg IV every 8 h | ||
| Ileus | and, if ileus, | ||
| Mental status changes | Vancomycin 500 mg in 500 mL saline as enema 4 times per day | ||
| WBC ≥ 35000 cells/mm3 or ≤ 2000 cells/mm3 | |||
| Serum lactate ≥ 2.2 mmol/L | |||
| End organ failure | |||
| Recurrent CDI | |||
| First recurrence | Metronidazole 500 mg by mouth 3 times per day for 10 to 14 d | ||
| or | |||
| Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |||
| or | |||
| Fidaxomicin 200 mg by mouth 2 times per day for 10 d | |||
| Second recurrence | -Tapered and pulsed vancomycin | ||
| or | |||
| Fidaxomicin 200 mg by mouth 2 times per day for 10 d | |||
| Subsequent recurrence | -Fecal microbiota transplant | ||
- Citation: D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4986